BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 25187453)

  • 21. Aberrant expression of β-catenin and E-cadherin is correlated with poor prognosis of nasopharyngeal cancer.
    Xu L; Jiang Y; Zheng J; Xie G; Li J; Shi L; Fan S
    Hum Pathol; 2013 Jul; 44(7):1357-64. PubMed ID: 23375645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aberrant expression and phosphorylation of beta-catenin in human colorectal cancer.
    Takayama T; Shiozaki H; Doki Y; Oka H; Inoue M; Yamamoto M; Tamura S; Shibamoto S; Ito F; Monden M
    Br J Cancer; 1998 Feb; 77(4):605-13. PubMed ID: 9484818
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Secreted Frizzled-related protein 1 (Sfrp1) regulates the progression of renal fibrosis in a mouse model of obstructive nephropathy.
    Matsuyama M; Nomori A; Nakakuni K; Shimono A; Fukushima M
    J Biol Chem; 2014 Nov; 289(45):31526-33. PubMed ID: 25253698
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ZEB1 promotes the progression and metastasis of cervical squamous cell carcinoma via the promotion of epithelial-mesenchymal transition.
    Ma Y; Zheng X; Zhou J; Zhang Y; Chen K
    Int J Clin Exp Pathol; 2015; 8(9):11258-67. PubMed ID: 26617850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Abnormal expression of beta-catenin and E-cadherin in Her2-positive breast cancer and its implications].
    Niu LG; He JJ; Wang K; Zhang W; Zhou C
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Nov; 29(11):2237-40. PubMed ID: 19923077
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined aberrant expression of E-cadherin and S100A4, but not β-catenin is associated with disease-free survival and overall survival in colorectal cancer patients.
    Lee SJ; Choi SY; Kim WJ; Ji M; Lee TG; Son BR; Yoon SM; Sung R; Lee EJ; Youn SJ; Park SM
    Diagn Pathol; 2013 Jun; 8():99. PubMed ID: 23783026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. L1 expression as a marker for poor prognosis, tumor progression, and short survival in patients with colorectal cancer.
    Boo YJ; Park JM; Kim J; Chae YS; Min BW; Um JW; Moon HY
    Ann Surg Oncol; 2007 May; 14(5):1703-11. PubMed ID: 17211730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-27a targets Sfrp1 to induce renal fibrosis in diabetic nephropathy by activating Wnt/β-Catenin signalling.
    Shi M; Tian P; Liu Z; Zhang F; Zhang Y; Qu L; Liu X; Wang Y; Zhou X; Xiao Y; Guo B
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32484208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemical study of E-cadherin and β-catenin expression in colorectal carcinomas.
    Ozgüven BY; Karaçetin D; Kabukçuoğlu F; Taşkin T; Yener Ş
    Pol J Pathol; 2011; 62(1):19-24. PubMed ID: 21574102
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Secreted frizzled-related protein 1 regulates the progression of neuropathic pain in mice following spinal nerve ligation.
    Tang J; Ji Q; Jin L; Tian M; Zhang LD; Liu XY
    J Cell Physiol; 2018 Aug; 233(8):5815-5822. PubMed ID: 29215727
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of tumor cell dissociation as a predictive marker of lymph node metastasis in submucosal invasive colorectal carcinoma.
    Hori H; Fujimori T; Fujii S; Ichikawa K; Ohkura Y; Tomita S; Ono Y; Imura J; Kuroda Y
    Dis Colon Rectum; 2005 May; 48(5):938-45. PubMed ID: 15785891
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nuclear E-Cadherin Acetylation Promotes Colorectal Tumorigenesis via Enhancing β-Catenin Activity.
    Zhao Y; Yu T; Zhang N; Chen J; Zhang P; Li S; Luo L; Cui Z; Qin Y; Liu F
    Mol Cancer Res; 2019 Feb; 17(2):655-665. PubMed ID: 30401720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical significance of altered expression of β-catenin and E-cadherin in oral dysplasia and cancer: potential link with ALCAM expression.
    Kaur J; Sawhney M; DattaGupta S; Shukla NK; Srivastava A; Walfish PG; Ralhan R
    PLoS One; 2013; 8(6):e67361. PubMed ID: 23840677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced E-cadherin facilitates renal cell carcinoma progression by WNT/β-catenin signaling activation.
    Zhang X; Yang M; Shi H; Hu J; Wang Y; Sun Z; Xu S
    Oncotarget; 2017 Mar; 8(12):19566-19576. PubMed ID: 28223537
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effects of CDH1 gene promoter methylation on expression of E-cadherin and beta-catenin and its clinicopathological significance in colon carcinoma].
    Li C; Dong J; Chen MQ; Li WL; Ren JY; Chen SX; Li QT; Geng JW; Miao YD; Yang J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Jul; 14(7):538-41. PubMed ID: 21792768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of E-cadherin, beta-catenin, and CD-44v6 cell adhesion molecules in primary tumors and metastases of colorectal adenocarcinoma.
    Delektorskaya VV; Perevoshchikov AG; Golovkov DA; Kushlinskii NE
    Bull Exp Biol Med; 2005 Jun; 139(6):706-10. PubMed ID: 16224588
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered distribution of beta-catenin, and its binding proteins E-cadherin and APC, in ulcerative colitis-related colorectal cancers.
    Aust DE; Terdiman JP; Willenbucher RF; Chew K; Ferrell L; Florendo C; Molinaro-Clark A; Baretton GB; Löhrs U; Waldman FM
    Mod Pathol; 2001 Jan; 14(1):29-39. PubMed ID: 11211307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Expression of Wnt5a, APC, β-catenin and their clinical significance in human colorectal adenocarcinoma].
    Cao YC; Yang F; Liu XH; Xin X; Wang CC; Geng M
    Zhonghua Zhong Liu Za Zhi; 2012 Sep; 34(9):674-8. PubMed ID: 23159080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The expression of E-cadherin and catenins in sporadic colorectal carcinoma.
    El-Bahrawy MA; Poulsom R; Jeffery R; Talbot I; Alison MR
    Hum Pathol; 2001 Nov; 32(11):1216-24. PubMed ID: 11727261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SFRP1 and SFRP2 suppress the transformation and invasion abilities of cervical cancer cells through Wnt signal pathway.
    Chung MT; Lai HC; Sytwu HK; Yan MD; Shih YL; Chang CC; Yu MH; Liu HS; Chu DW; Lin YW
    Gynecol Oncol; 2009 Mar; 112(3):646-53. PubMed ID: 19095296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.